Skip to main content
. 2022 Apr 13;12:804611. doi: 10.3389/fcimb.2022.804611

Figure 1.

Figure 1

Duration of broad-spectrum antimicrobial therapy. (A, B). Numbers of days of (A) broad-spectrum antimicrobial therapy (activity against P. aeruginosa), and (B) carbapenems with anti-pseudomonas aeruginosa activity in real-life, in the FAPP-based simulated treatment, and the recommendations-based simulated treatment. FAPP, FilmArray® Pneumonia plus Panel. *p < 0.01, ***p < 0.001.